AdaptHealth Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on December 3, 2019, reporting events occurring on November 27, 2019. AdaptHealth Corp. (AHCO) is a Delaware corporation that consummated a business combination on November 8, 2019. Following the combination, its Class A common stock began trading on The Nasdaq Capital Market under the symbol "AHCO."
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on listing status and regulatory compliance.
Material Changes
On November 27, 2019, the Company received notification from Nasdaq regarding the listing status of its securities:
- Class A Common Stock: The Nasdaq Staff determined that the stock satisfied the requirements for initial listing on the Nasdaq Capital Market.
- Warrants (AHCOW): The Company is not in compliance with Nasdaq Listing Rule 5515(a)(4), which requires a minimum of 400 round lot holders for warrant listing.
Outlook, Risks, and Unusual Items
Delisting of Warrants: The Company does not intend to appeal Nasdaq's determination regarding the warrants. Consequently, the warrants will be delisted from Nasdaq and suspended at the opening of business on December 6, 2019. A Form 25-NSE will be filed to effect this removal.
Impact on Operations: The delisting does not affect the terms of the warrants, which remain exercisable for Class A common stock at $11.50 per share. The continued listing of the Class A common stock is unaffected by the warrant delisting.
Investor Verification Checklist
- Confirm the suspension date of warrant trading (December 6, 2019).
- Verify that warrant exercise rights remain intact despite delisting.
- Check subsequent filings (Form 25-NSE) to confirm the official removal of warrants from Nasdaq registration.
- Monitor the number of round lot holders to understand the specific compliance failure cited by Nasdaq.